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Study objectives: We investigated associations between actigraphy-assessed sleep measures and 
cognitive function in people with and without HIV using different analytical approaches to better 
understand these associations and highlight differences in results obtained by these approaches. 
Methods: Cognitive and 7-day/night actigraphy data were collected from people with HIV (PWH) 
and lifestyle-similar HIV-negative individuals from HIV and sexual health clinics in UK/Ireland. A 
global cognitive T-score was obtained averaging the standardized individual cognitive test scores 
accounting for socio-demographics. Average and standard deviation (SD) of eleven sleep measures 
over 7-days/nights were obtained. Rank regression, partial least-squares (PLS) regression, random 
forest, sleep dimension construct, and latent class analysis (LCA) were applied to evaluate 
associations between global T-scores and sleep measures. 
Results: In 344 PWH (median age 57 years, 86% males), average sleep duration, efficiency and wake 
after sleep onset were not associated with global T-scores according to rank regression (p=0.51, 
p=0.09, p=0.16, respectively). In contrast, global T-scores associated with average and SD of length 
of nocturnal awakenings, SD of maintenance efficiency and average out-of-bed time when analyzed 
by PLS regression and random forest. No associations were found when using sleep dimensions or 
LCA. Overall, findings observed in PWH were similar to those seen in HIV-negative individuals 
(median age 61 years, 67% males). 
Conclusions: Using multivariable analytical approaches, measures of sleep continuity, timing and 
regularity were associated with cognitive performance in PWH, supporting the utility of newer 
methods of incorporating multiple standard and novel measures of sleep-wake patterns in 
assessment of health and functioning.   



















Statement of significance 
This is the first study to apply different machine learning approaches to assess the link between 






















Widespread access to combination antiretroviral therapy has meant that HIV is now a manageable 
chronic disease for many of those affected [1]. Nevertheless, the quality of life of people with HIV 
(PWH) remains poorer than that of the general population, in part due to an increased burden of co-
morbidity [2], including highly prevalent and diverse sleep problems [3]. Established aetiological 
pathways and risk factors for sleep problems in the general population may be exacerbated in PWH 
by the additional prevalence of several psychosocial and behavioral factors also known to disrupt 
sleep (e.g. depression, stress, excessive worry [4,5]), by inflammation and neuronal damage induced 
by HIV [6] and by adverse effects of antiretroviral therapy [7].  
Cognitive disorders also remain prevalent among PWH, especially mild or moderate disorders [8], 
with a reported prevalence often exceeding that seen in HIV-negative populations [9]. Sleep 
deprivation and/or fragmentation can be responsible for alterations of toxin clearance and synaptic 
function, potentially contributing to impairment of many cognitive functions [10]. Whilst several 
studies have demonstrated the negative effect of poor subjective [11] and objective [12, 13] sleep 
health on cognitive function of adults from the general population, little is known regarding the 
association between sleep and cognition in PWH, with limited evidence suggesting a link between 
poor self-reported sleep quality and cognitive disorders. However the few studies on PWH that have 
investigated these associations, either relied on a limited sample size [14], on self-reported sleep 
quality [15] or lacked a control group of HIV-negative individuals [16]. Moreover, most of the studies 
that have investigated the link between sleep and cognition in the general population have either 
considered subjective measures of sleep [11] or have focused on sleep duration only [12,13], with 
only a few investigating the role of multiple dimensions of  sleep [17-21].  Thus information on 
associations between objective measures of sleep and cognitive function is lacking. 
The idea of sleep health as a multi-dimensional construct [22] recognizes that different aspects of 
sleep (e.g. duration, efficiency, timing, regularity) may all be important and have differential effects 
on health. Therefore, investigation of a single sleep characteristic only (for example, sleep duration) 
may lead to a limited understanding of the broader implications of poor sleep health. The 
introduction of accelerometers in clinical research has allowed researchers to objectively quantify 
various aspects of sleep over a prolonged period of time. Recently, there has been increasing 
interest in using a variety of statistical methods to exploit these data for studying  the effect of sleep 
on health outcomes [23]. Several studies have begun to consider multiple sleep characteristics using 
multivariate analytical methods, such as random forests, to handle high-dimensional and correlated 
sleep data [24]. Other studies have examined sleep as a multidimensional construct and have 
described the association of a composite sleep score or individual sleep dimensions on a given 
outcome [25, 26]. Individual-based approaches have also been applied, such as cluster and latent 
class analysis (LCA), to identify sleep health ‘profiles’ based on several sleep characteristics and then 
investigate differences in health outcomes across the different ‘profiles’ *27].  
These are conceptually different approaches each of which can provide important insight into the 
association between sleep and health outcomes. However, intrinsic differences related to the nature 
of these approaches and their specific aims can potentially lead to different conclusions about the 



















Our overarching aim was to assess the association between sleep health and cognitive function in 
both PWH and HIV-negative controls, and shed light on those aspects of sleep most strongly linked 
to cognition. While addressing this study question, we sought to evaluate several different statistical 
approaches that differ in how they take into account the relationships between sleep parameters. 
Secondly, when possible, we investigated the extent to which associations between sleep health and 
cognitive function may differ by HIV-status. 
Methods 
Study participants and procedures 
The Pharmacokinetic and Clinical Observations in People Over Fifty (POPPY) study is an observational 
cohort study of PWH and HIV-negative individuals with similar lifestyles from UK and Ireland. The 
study recruited three groups of individuals and has been described previously [28]. Briefly, two 
groups of PWH were recruited from eight HIV clinics: PWH aged ≥50 years and PWH aged 18-50 
years, with the latter group frequency matched on gender, ethnicity, sexual orientation and location 
to the older group of PWH. Inclusion criteria were: documented presence of HIV infection, white or 
black-African ethnicity, likely route of HIV acquisition via sexual exposure and ability to comprehend 
the study information leaflet. A group of HIV-negative individuals was also recruited from sexual 
health centers affiliated to the HIV clinics: these individuals were required to be 50 years or older 
and to have a documented negative HIV test. In addition, this group was frequency matched to the 
group of PWH aged ≥50 years on gender, ethnicity, sexual orientation and location.   
Subsets of POPPY study participants from the three groups were recruited into this nested sub-
study, without regard to sleep symptoms. Additional inclusion criteria were: ability to wear a 
fingertip oximetry device and wrist actigraph for a week and to adhere to study procedures 
(according to the investigator’s judgement).  
Participants underwent a single study visit between March 2017 and July 2018 followed by in-home 
procedures including a daily sleep diary, actigraph and oximetry measurements and an additional 
visit to return the devices and the completed diaries. At the study visit, participants completed 
questionnaires detailing sleep quality, symptoms of sleep disorders, sleep medical history and 
medication use for sleep disorders, and underwent detailed assessment of anthropometric 
measurements and cognitive function. All participants provided written informed consent and the 
study was approved by the UK Research Ethics Committee (REC; Fulham, London; UK number 
16/LO/1409) and local ethics committees and/or institutional review boards. For the present 
analysis, only participants with at least 5 days/nights’ worth of valid actigraphy data and with 
completed cognitive assessment were included. 
Cognitive function 
Participants underwent detailed assessment of cognitive function using a comprehensive battery of 
nine tests covering five domains known to be affected by HIV-associated cognitive impairment: 
language, attention, processing speed, executive function and motor function (Supplementary Table 
1) [8]. The battery was administered by trained research staff. Individual test scores were converted 



















accounting for age, gender, ethnicity and education as appropriate. Individual test T-scores were 
averaged to obtain domain T-scores which were, in turn, averaged to obtain a global T-score of 
cognitive function. Higher T-scores indicate better cognitive function.  
Actigraphy data 
A triaxial actigraph device (ActiGraph wGT3X-BT®, ActiGraph Corporation) was used to record 
activity data and estimate sleep parameters. Actigraphs were programmed to collect data at a 
sampling rate of 100Hz and participants were instructed to wear the device on the non-dominant 
wrist continuously until the time of return (a minimum of 7 days later), with removal only when 
needed to avoid damage to the device (e.g. contact sports, swimming, bathing). In addition, daily 
sleep diaries were completed at home by study participants describing timing of sleep, nocturnal 
awakenings, daytime napping and interruptions in the use of the actigraph device. 
Upon return of the device to study sites, data from the devices were downloaded at an epoch length 
of 15 seconds. After successful download, digital datafiles were transferred to the sleep reading 
center for central scoring. For each recording day, the sleep (or “rest”) periods were manually 
annotated based on a combination of sleep diary data (reporting bed and wake times) and 
visualization of an abrupt decrease (<1000 counts) and increase (≥ 1000 counts) in activity for 5 or 
more minutes, respectively. Daytime naps were scored based on identifying periods reported in the 
sleep diary as naps, accompanied (within 30 mins) by decreased activity. Sleep-wake epochs were 
then identified using the Cole-Kripke algorithm [29]. Daily sleep measures were obtained including 
sleep onset, midpoint (clock time between sleep onset and offset) and out-of-bed time, onset 
latency, duration (total time spent asleep), wake duration after sleep onset (WASO), maintenance 
efficiency (% of time spent asleep from sleep onset and sleep offset), movement index (% of 60-s 
epochs with movement divided by time spent in bed in hours), fragmentation index (% of 60‐s sleep 
epochs out of the total number of epochs in the sleep period), and number and length of nocturnal 
awakenings. For each participant, the average and the within-individual variability (i.e. the standard 
deviation: SD) across the observation period were obtained for each of these measures. 
Sleep questionnaires 
Sleep questionnaires were administered at study visits, including the Insomnia Severity Index [30] 
and the Patient-Reported Outcomes Measurement Information System sleep disturbance and sleep-
related impairment questionnaires [31+. In particular, answers to questions related to participants’ 
satisfaction with their current sleep from these two questionnaires were analyzed: “How 
satisfied/dissatisfied are you with your current sleep pattern?” and “I was satisfied with my sleep”, 
respectively. 
Sleep dimensions 
Six dimensions of sleep health as proposed by Buysse [22], i.e. satisfaction, alertness, timing, 
efficiency, duration and regularity (the so-called RU SATED scale [32]), were derived from the daily 
actigraphy measures and questionnaire data. Scores for the dimension of satisfaction were 
determined as follows: 2 (i.e. “good”) if answering ‘Very satisfied’ or ‘Moderately satisfied’ to the 



















‘Very much’ to the “I was satisfied with my sleep” question; 0 (i.e. “poor”) if answering ‘Dissatisfied’ 
or ‘Very dissatisfied’ and ‘Not at all’ or ‘A little bit’, respectively, to the same questions; and 1 (i.e. 
“fair”) in all other circumstances.  
In addition to continuous measures summarizing weekly averages and standard deviations, daily 
number of naps, sleep onset and out-of-bed time, maintenance efficiency and duration as measured 
by the actigraphy device were used to derive dichotomous variables indicating ‘good’ vs ‘bad’ health 
for the dimensions of alertness, timing, efficiency, duration and regularity. For each recorded night, 
‘good’ vs ‘bad’ sleep health was defined as follows: 0 naps vs. ≥1 naps (alertness), sleep onset time 
before 2am and out-of-bed time after 4am vs onset time after 2am or out-of-bed time before 4am 
(timing), maintenance efficiency ≥85% vs <85% (efficiency), sleep duration between 6 and 8 hours vs 
<6 or >8 hours (duration), sleep onset time within 30 minutes of the average sleep onset time across 
the whole observation period vs onset time ≥30 minutes before or after the average onset time 
(regularity). Cut-offs were selected to reflect the dimensions as originally proposed by Buysse [22], 
with the exception of sleep efficiency for which a current recommendation was used [33]. For each 
dimension, a score of 2 (i.e. “good”) indicates ≥70% of recorded nights classified as ‘good’, 1 (i.e. 
“fair”) indicates between 30% and 70% of ‘good’ nights, and 0 (i.e. “poor”) indicates <30% of ‘good’ 
nights. 
A total sleep health score was obtained by summing up the scores from the six dimensions; scores 
range from 0 to 12 with higher values indicating better sleep health. 
Statistical analysis 
Continuous variables, including cognitive T-scores and actigraphy measures, were summarized using 
the median and the interquartile range (IQR); categorical variables were described using frequencies 
and percentages. Comparisons of sociodemographic, lifestyle and clinical characteristics across older 
PWH, younger PWH and HIV-negative individuals were carried out using χ2, Fisher’s exact test and 
Wilcoxon rank‐sum tests as appropriate. The two groups of PWH were subsequently combined into 
a single group of PWH; comparisons of actigraphy measures and cognitive scores between PWH and 
HIV-negative individuals were performed using median regression, adjusting for age. 
Different approaches to evaluate the association between actigraphy-assessed sleep measures and 
global cognitive function (i.e. the global T-score obtained as average of the five domain T-scores) 
were applied. These approaches have been previously used to investigate the link between sleep 
and health outcomes, as also reviewed by Matricciani et al. [23]. A brief overview of these methods 
with advantages and disadvantages of each method is reported in Table 1; further details concerning 
their use in this study are given below.  
i. Traditional approach: we investigated individual sleep measures selected based on prior 
knowledge and hypothesized pathological mechanisms [34,35], i.e. the average sleep duration, 
maintenance efficiency and WASO. Associations with global cognitive T-scores were evaluated 
using rank regression to account for the skewness of variables of interest, adjusting for 



















For sleep duration, where a U-shaped relationship with cognitive function can be expected, we 
also evaluated the absolute value of the difference between the observed duration and the 
median sleep duration (i.e. 7 hours). Each sleep measure was analyzed independently (using 
separate regression models) and also simultaneously in a single regression model also including 
potential confounders. Analyses were conducted separately in PWH (older and younger PWH 
combined) and HIV-negative individuals; the interaction between HIV-status and each sleep 
measure was tested using rank regression (also including potential confounders) to evaluate 
differences in the associations between the two groups.  
ii. Partial least squares (PLS) regression [36]: this multivariate approach was applied separately in 
PWH and HIV-negative individuals, to the averages and SDs of all continuous sleep measures 
(sleep onset, midpoint and out-of-bed time, onset latency, duration, WASO, maintenance 
efficiency, movement index, fragmentation index, number and length of nocturnal awakenings, 
i.e. a total of 22 variables) to predict global cognitive T-scores. All variables were centered and 
scaled to unit variance. For each variable, the variable importance for prediction (VIP) was 
calculated as a measure of the strength of the association between that variable and the global 
T-score [37] and in order to rank sleep measures with respect to their association with cognitive 
function.  
iii. Random forest [38]: this multivariate approach was also applied separately in PWH and HIV-
negative controls, with sleep measures (both the average and SD) and potential confounders 
(age, gender, ethnicity, education and use of sleep medication) as inputs (a total of 22 sleep 
measures plus 5 covariates) and the global cognitive T-score as the outcome. Among PWH (HIV-
negative individuals), the random forest approach fitted 5000 (8200) regression trees, each of 
which utilized 15 (5) randomly chosen variables of the 27 input variables (see also 
Supplementary Material) and empirically selected those that optimally split the sample into 
two sub-groups with global T-scores that were as different as possible. For each input variable, 



















squares from splitting on that variable, averaged over all trees. VIM was used to rank input 
variables in terms of their ability to predict the global T-score; variables with larger VIM have 
greater predictive ability. In addition, importance of each variable was assessed by comparing 
the reduction in the R2 consequent to the exclusion of that variable from the model. 
iv. Sleep health as a multi-dimensional construct: we investigated associations of each sleep 
dimension and their sum in the previously proposed six-item RU SATED scale with global 
cognitive T-scores. Associations were investigated, separately in PWH and HIV-negative 
individuals, using median regression to test differences in overall cognitive function between 
individuals reporting good, fair and poor sleep in each dimension, when there were at least 5 
individuals in a given group. The six dimensions were considered individually in separate 
models. The association between global T-scores and the total sleep health score obtained as 
the sum of the six dimensions was assessed using rank regression. In all the regression models, 
we adjusted for age, gender, ethnicity, education and use of sleep medication.   
v. Latent class analysis (LCA) [39]: this individual-based approach was used to identify distinct 
groups of PWH and, separately, of HIV-negative individuals on the basis of the observed 
sleep measures (both averages and SDs) centered and scaled to unit variance. Groups were 
identified using a model-based clustering algorithm based on parameterized finite Gaussian 
mixture models [40]. The optimal number of groups was selected using the Bayesian 
Information Criterion (BIC) and was evaluated using the bootstrap likelihood ratio test and 
appropriate stability measures. In order to interpret the obtained groups, means and 95% 
confidence intervals (CIs) of each sleep measure were obtained within each identified group. 
Median regression was used to evaluate the difference in global cognitive T-scores between 
groups returned by the LCA, while adjusting for age, gender, ethnicity, education and use of 
sleep medication.   
Additional information regarding hyper-parameter optimization, validation procedures, and the 



















Material. Analyses were performed using the using the statistical software R, version 3.6.0 and the 
libraries ‘quantreg’, ‘ropls’, ‘randomForest’ and ‘mclust’.   
Results 
Participant characteristics 
A total of 241 older PWH, 103 younger PWH and 119 HIV-negative individuals completed the 
cognitive battery and had ≥5 days/nights of actigraphy data (Table 2). Compared to the HIV-negative 
individuals, PWH were more likely to be male (86.3% vs. 67.2%, p<0.001), men who have sex with 
men (79.1% vs. 52.9%, p<0.001), be retired or not working (48.3% vs. 37.1%, p=0.006) and to report 
ongoing use of sleep medication (8.7% vs. 1.7%, p=0.006), current smoking (26.2% vs. 15.1%, 
p=0.01), recreational drug (26.7% vs. 14.3%, p=0.006) and current/previous injection drug use (9.3% 
vs. 1.7%, p=0.004). Current alcohol use was more frequent among HIV-negative individuals 
compared to older PWH (91.6% vs. 81.1%, p=0.007).  
PWH had been diagnosed with HIV for a median (IQR) of 17.6 (10.8, 24.6) years, 97.1% had a HIV 
RNA <40 copies/mL, and the median (IQR) CD4+ cell count was 630 (483, 835) cells/μL. 
Cognitive scores and sleep measures 
Median (IQR) global T-score was 50.7 (44.3, 55.4) in older PWH, 48.7 (43.0, 54.0) in younger PWH 
(p=0.15 compared to older PWH) and 52.0 (48.3, 55.6) in HIV-negative individuals (p=0.04 compared 
to older PWH). When combining older and younger PWH, global T-scores did not differ significantly 
from those of HIV-negative individuals [median (IQR) in the combined group of PWH was 50.0 (44.2, 
54.9), p=0.21 after adjusting for age, Supplementary Table 2].  
Correlations between actigraphy variables are shown in Supplementary Table 3. There were no 
differences between PWH and HIV-negative individuals, after adjusting for age, with regards to 
average sleep onset time, onset latency, duration, WASO, fragmentation index and number of 
nocturnal awakenings (Supplementary Table 2). PWH were observed to have later average sleep 
mid-point and out-of-bed times compared to HIV-negative individuals (p=0.01 and p=0.02, 
respectively). The average movement index (%) was greater in PWH compared to HIV-negative 
individuals [median (IQR): 17.7 (14.3, 22.5) vs. 15.2 (12.5, 19.6), p=0.003], with a tendency towards 
lower average maintenance efficiency (p=0.07) and greater mean length of awakenings (p=0.08) in 
PWH compared to HIV-negative individuals.  
There were significant differences between groups with respect to the night-to-night variability of 
sleep onset time (p=0.05), duration (p=0.01) and movement index (p=0.04), with weaker evidence 
regarding fragmentation index (p=0.07) and mean length of nocturnal awakenings (p=0.08). For all 
these measures, there was a greater night-to-night variability in PWH compared to HIV-negative 
individuals. 
Finally, PWH were classified as having poorer overall sleep health as measured by the RU SATED 
construct: median (IQR) sleep health score was 7 (6, 9) in PWH and 8 (7, 10) in HIV-negative 



















poorer sleep health than HIV-negative individuals in the satisfaction (p=0.008), timing (p=<0.001) 
and duration (p=0.001) dimensions (Supplementary Table 4). Weaker evidence suggests that PWH 
experienced poorer health in the other sleep dimensions: alertness, efficiency and regularity, 
although only the associations with regularity met the strict threshold for statistical significance 
(p=0.07, p=0.07 and p=0.05 for the three dimensions, respectively). 
Association between sleep health and overall cognitive function 
Traditional approach 
Among PWH, global cognitive T-scores were not associated with average sleep duration (adjusted 
rho = 0.08, p=0.12), WASO (adjusted rho = -0.03, p=0.55) or maintenance efficiency (adjusted rho = 
0.06, p=0.25, after adjustment for potential confounders (Table 3). Whilst there was no strong 
evidence of an association with the absolute value of the median-centered sleep duration (p=0.36) 
in PWH, longer/shorter sleep duration was associated with poorer cognitive function in HIV-negative 
individuals (adjusted rho = -0.21, p=0.02). Among HIV-negative individuals, higher WASO (adjusted 
rho = 0.16) and lower maintenance efficiency (adjusted rho = -0.16) were associated with better 
cognitive function, although associations did not reach statistical significance (p=0.08 and p=0.07, 
respectively). However, observed associations did not significantly differ between PWH and HIV-
negative individuals (all p’s for the interaction term >0.05).  
In multivariable analysis, maintenance efficiency showed the strongest association with the global T-
score in PWH but without reaching statistical significance (adjusted rho = 0.26, p=0.09), with greater 
efficiency being associated with better cognitive scores. Among HIV-negative individuals, sleep 
duration remained significantly associated with global T-scores (adjusted rho of -0.25, p=0.008), with 
no associations for WASO and maintenance efficiency (p=0.49 and p=0.85, respectively; Table 3). 
Multivariate approach: PLS 
Among PWH, PLS extracted one predictive component (PLS score) obtained as a linear combination 
of the 22 actigraphy variables. This component explained 40.6% of the total variance in the 
actigraphy variables and was significantly correlated with the global T-score [rho = 0.30 (0.20, 0.39), 
p<0.001]. The variables that contributed the most to the PLS score were: SD of mean length of 
awakenings (VIP=1.77), average of mean length of awakenings (VIP=1.67), SD of maintenance 
efficiency (VIP=1.45), average duration (VIP=1.27), SD of movement index (VIP=1.25), SD of out-of-
bed time (VIP=1.24), average sleep onset time (VIP=1.23) and SD of duration (VIP=1.22, Figure 1). 
Specifically, as indicated by negative weights, greater variability in mean length of awakenings, 
maintenance efficiency, movement index, out-of-bed time and duration, and later average onset 
time were all associated with poorer cognitive scores. Longer average sleep duration (positive 
weight) was associated with better scores.      
Among HIV-negative individuals, one component was extracted, explaining 38.5% of the total 
variance in the actigraphy variables. The component was significantly correlated with the global T-
score [rho = 0.38 (0.22, 0.52), p<0.001] and VIP was the highest for SD of mean length of awakenings 
(VIP=2.64), average of mean length of awakenings (VIP=2.36), SD of fragmentation index (VIP=1.66), 



















of the respective weights, greater variability of mean length of awakenings, fragmentation index and 
movement index, and longer average of mean length of awakenings were associated with poorer 
cognitive scores. A greater average number of awakenings was linked to better cognitive scores. 
Multivariate approach: random forest 
The VIMs for the 22 actigraphy variables derived from random forest and expressed as the 
percentage relative to the variable with the highest VIM are reported in Figure 1. Among PWH, the 
average mean length of awakenings showed the highest VIM among all the actigraphy variables (the 
corresponding average decrease in residual sum of squares was 1133.1) to separate PWH with 
different cognitive scores. VIM was also high for the SD of mean length of awakenings (90.9% of VIM 
of average mean length of awakenings), average sleep duration (82.4%), SD of out-of-bed time 
(81.1%) and average sleep onset time (79.2%).  
Among HIV-negative individuals, the SD of mean length of awakenings showed the greatest ability to 
predict global cognitive scores, with an average decrease in residual sum of squares of 284.6). VIM 
for the average sleep onset time, sleep mid-point, fragmentation index and movement index were 
88.2%, 71.9%, 71.5% and 71.4%, respectively of the VIM of the SD of mean length of awakenings.  
Sleep health as a multi-dimensional construct 
None of the six sleep dimensions (satisfaction, alertness, timing, efficiency, duration and regularity) 
was individually significantly associated with overall cognitive function of PWH (Figure 2). Efficiency 
was the only dimension approaching statistical significance (p=0.06) with cognitive scores; PWH with 
fair efficiency (i.e. poor efficiency during 30%-70% of nights) showed poorer cognitive scores than 
PWH with good sleep efficiency [adjusted difference in global T-score (95% CI) = -2.7 (-5.3, -0.2), 
p=0.04]. For all other dimensions, the median global T-score did not appear to differ significantly 
across PWH with poor, fair or good sleep health, after adjustment for potential confounders. 
Among HIV-negative individuals, sleep efficiency appeared to be associated with overall cognitive 
function (p=0.04), with individuals reporting fair efficiency showing better cognitive scores than 
those reporting high efficiency [adjusted difference in global T-score (95% CI) = 4.3 (1.0, 7.7), 
p=0.01]. This association appeared to differ from that seen in PWH (p for interaction = 0.002). 
Associations of other sleep dimensions with the global T-score were weak and non-significant (Figure 
2) and did not differ significantly from associations observed in PWH (interaction p=0.16 for 
satisfaction, p=0.96 for alertness, p=0.85 for duration, and p=0.88 for regularity). 
Finally, the association of the total sleep health score with overall cognitive function was weak in 
both PWH and HIV-negative individuals [adjusted rho (95% CI) = 0.04 (-0.06, 0.14), p=0.42 and -0.05 
(-0.24, 0.13), p=0.57, respectively]. There was also no evidence that the association differed by HIV 
status (p for interaction = 0.25).   
Individual-based approach: LCA 
According to the BIC criteria and stability measures (Supplementary Figures 4 and 5), a model with 
two latent groups was identified based on sleep parameters observed in PWH. The mean and 95% CI 



















Figure 3. Group 1 included the majority of PWH (n=331, 96.2%) with only 13 (3.8%) PWH in Group 2. 
Compared to PWH in Group 1, those in Group 2 had later average time of sleep onset and mid-point, 
earlier average time of out-of-bed, longer average onset latency and WASO, shorter average 
duration, poorer average maintenance efficiency, greater average movement index, fragmentation 
index, number and length of nocturnal awakenings. Variability of all sleep measures except 
fragmentation index was greater among PWH in Group 2 compared to those in Group 1. The median 
(IQR) global T-score was 50.0 (44.2, 54.9) and 50.0 (45.7, 52.4) in PWH in Group 1 and 2, 
respectively. After adjustment for potential confounders, the difference between the two groups 
was not significant [adjusted difference in global T-score (95% CI) = 1.4 (-2.4, 4.0), p=0.59].  
Two groups were also identified by the LCA in HIV-negative individuals (Figure 3). Compared to 
individuals in Group 1 (n=93, 78.2%), those in Group 2 (n=26, 21.8%) showed later average mid-point 
and out-of-bed time, longer average onset latency and WASO, lower average maintenance 
efficiency, greater average movement, fragmentation and mean length of awakenings. In Group 2, 
the night-to-night variability of all the variables except for fragmentation index was greater 
compared to that observed in individual in Group 1. The median (IQR) global T-score was 52.9 (48.4, 
55.9) and 51.5 (47.7, 54.7) in HIV-negative individuals in Group 1 and 2, respe tively. These did not 
differ significantly after controlling for potential confounders [adjusted difference in global T-score 
(95% CI) = 0.1 (-2.7, 2.7), p=0.97]. 
Discussion 
This is the first study, to our knowledge, that has comprehensively assessed the relationships 
between objectively measured, actigraphy-assessed sleep characteristics and cognitive function in a 
multi-centre cohort of PWH, with an appropriate control group. We also applied several analytical 
approaches to these complex, correlated, and multi-dimensional actigraphy data and found that 
interpretation of results differed by the analytic approach used, highlighting the importance of more 
advanced machine learning approaches to better handle these complex data and shed light on the 
impact of sleep on health outcomes.   
When we applied the traditional approach of investigating individual sleep characteristics 
hypothesized to have an impact on cognition and other health outcomes, we observed only weak 
associations between cognitive function and sleep duration, sleep efficiency and WASO, in line with 
a previous study of 36 treated PWH [41].  
Multivariate approaches such as PLS regression and random forest permit the investigation of a 
larger number of sleep characteristics as well as consideration of within-individual variability of 
these over a period of time, overcoming issues related to multicollinearity between sleep measures, 
multiple testing and the estimation of large numbers of parameters. Here, both methods seem to 
indicate that longer nocturnal awakenings and greater within-individual variability of awakenings is 
associated with poorer cognitive function in PWH, with stronger associations than seen with any 
other sleep measure considered. Furthermore, other aspects related to the intra-individual 
variability of sleep patterns (e.g. the variability of sleep maintenance efficiency and out-of-bed time) 
appeared to have a negative effect on overall cognitive function of PWH, with average sleep 
duration itself playing a marginal role. These are novel findings, given the limited number of studies 



















Of studies that have gone beyond sleep duration, several have shown similar results in 
demonstrating potential deleterious cognitive impact of poor sleep continuity, as indicated by 
objectively-measured WASO, sleep efficiency or number of nocturnal awakenings, to which sleep 
duration appeared to add little [17, 20, 21]. Nevertheless, we have investigated a larger array of 
measures underlying the variability of sleep patterns than previous studies. Our findings suggesting 
the potential deleterious cognitive impact of high night-to-night variability of sleep efficiency, high 
variability of sleep fragmentation, and longer duration of nocturnal awakenings have not been 
comprehensively investigated previously and could result from important behavioral, social and 
environmental factors as well as circadian or homeostatic drive. Whilst these findings require further 
validation in other cohorts, it is possible that chronic disruptions to the circadian rhythm and 
homeostatic drive could affect the function and structure of brain regions such as the prefrontal 
cortex [42], responsible for high-order cognitive functions. Our study did not include formal 
assessments of circadian rhythm (e.g. dim light melatonin onset, core body temperature tracking) 
and an actigraphy-derived analysis of circadian rhythm was beyond the scope of this current 
analysis, but such future analyses will be important to a more comprehensive understanding of how 
sleep and circadian rhythms relate to cognition.   
The use of a composite sleep score and pre-defined sleep dimensions failed to reveal any strong 
association between sleep and cognition in PWH, with only sleep efficiency showing a weak 
association that was close to reaching statistical significance. Finally, an individual-based approach 
such as LCA, which aims to identify homogenous groups of individuals with similar sleep profiles, 
also failed to detect any important relationships between objective sleep measures and cognition. 
Whilst LCA identified two distinct groups of PWH distinguishing those with more irregular, 
fragmented and inefficient sleep patterns from the rest of PWH, it showed no evident differences in 
the cognitive performance of the two groups.  
Another important aim of our study was to assess whether the association between sleep measures 
and cognitive function in PWH differed from those seen in HIV-negative individuals with similar 
lifestyles. Of the approaches explored, we could formally compare associations by HIV status using 
the traditional approach (i.e. specific sleep characteristics using regression models) and the overall 
sleep score because PLS regression, random forest and LCA don’t allow assessment of interaction 
terms. In general, associations did not seem to differ between PWH and HIV-negative individuals. 
However, the direction of the association between cognitive function and sleep efficiency appeared 
to be significantly different in the two groups when using a categorical score reflecting the frequency 
of poor efficiency. Whilst the possibility of a false positive finding cannot be ruled out, the 
differential association may reflect different underlying causes of poor sleep efficiency in those with 
and without HIV, so further studies are warranted to better elucidate the effects of sleep efficiency 
on cognitive outcomes in PWH. 
PLS regression and random forest highlight some similarities between the associations seen in PWH 
and HIV-negative individuals. In particular, length of nocturnal awakenings and the within-individual 
variability in this measure seem to have a similarly important relationship to cognitive performance, 
regardless of HIV status. On the other hand, among HIV-negative individuals, aspects related to sleep 
fragmentation and overnight movement/limb motions are more strongly associated with cognition 



















neurophysiology (e.g. reduced slow-wave sleep and rapid eye movement) reflected by greater sleep 
fragmentation causing less restorative sleep and leading, in turn, to deleterious effects on cognition. 
By adopting a multi-method analytic approach, we comprehensively and robustly investigated the 
proposed associations beyond the limitations of each analytical method, while also highlighting the 
differences in the findings across methods. Each approach used has its own strengths as well as 
weaknesses (Table 1). The traditional approach may fail to detect associations of individual and 
often neglected sleep characteristics that are not selected when only few characteristics are 
analyzed. PLS regression does not allow the incorporation of potential confounders into analyses 
and assumes a linear relationship between the sleep measures and the outcome of interest. Random 
forest does not provide a direct measure that would allow the evaluation of either the direction or 
magnitude of any associations. Moreover, variable importance metrics obtained from random 
forests are known to be biased when input variables are of different measurement scales and when 
are highly correlated [43]. Nevertheless, here we also reported another importance metric (i.e. the 
decrease in R2 due to the exclusion of a given variable from the model, Supplementary Figure 3) that 
showed results similar to the VIMs, in terms of the actigraphy variables which appear to more 
strongly contribute towards the prediction of cognitive scores. Multi-dimensional sleep constructs 
rely heavily on a priori conceptualizations of sleep health which may not be appropriate for a specific 
health outcome or a unique population such as PWH. Moreover, statistical power is reduced when 
continuous measures are dichotomized. LCA does not directly aim to evaluate associations with 
outcomes but rather aims to partition the population under study into groups based on the 
observed sleep characteristics, without regards to the outcome of interest; therefore the obtained 
groups may not necessarily identify those at greatest risk of a poor outcome nor, in turn, the sleep 
characteristics that might predict this outcome.  
Some limitations of our study need to be considered. Firstly, given the cross-sectional nature of the 
study, we cannot establish the direction or causal nature of any associations seen. Secondly, 
unmeasured confounding (e.g. physical exercise and stress) may have resulted in biased estimates of 
the associations of interest. Thirdly, PWH recruited in this study are mainly white men having sex 
with men, on effective HIV treatment with stable viral suppression, and therefore our results may 
not be generalizable to other populations of PWH with different socio-demographic and clinical 
characteristics, in particular women and PWH with poorly controlled HIV. Moreover, differences in 
terms of age and age-related factors between PWH and HIV-negative individuals may have 
introduced bias when comparing the relationship between sleep and cognition across the two 
groups. However, when possible, we included age and other potential confounders in the analysis so 
to minimize this potential bias. Sample size was pragmatically set considering resource and time 
constraints and was not based on the statistical power of any of the methods used. Whilst our study 
is one of largest in its fields, some methods, for example LCA, may have lower power to detect 
significant associations than others, sample size being equal. Lastly, we used actigraphy-based 
assessments of sleep parameters rather than more detailed sleep measurements such as 
polysomnography. We therefore could not study detailed sleep physiology and mechanisms. Future 
studies incorporating polysomnogram data would likely benefit from machine learning approaches 
similar to our study, given the multi-dimensional and often collinear nature of polysomnogram data. 
We feel that such work with detailed physiologic measures and robust statistical approaches have 
tremendous potential to allow our field to better understand mechanistic pathways and to develop 




















Through the use of analytical approaches that allow the simultaneous consideration of multiple 
sleep characteristics, we found that aspects related to sleep continuity and regularity, including 
several novel measures of within-individual variability of wakefulness during sleep and sleep 
efficiency, were associated with cognitive performance in PWH. Other aspects of sleep more 
traditionally thought to be related to health problems (e.g. sleep duration) did not appear to have 
strong associations. Sleep is increasingly recognized as having a multi-dimensional construct, and our 
analysis demonstrates that multivariate analytical approaches can provide novel insights into the 
role of sleep on cognitive function and other health outcomes. A better understanding of which 
aspects of sleep are most strongly linked to a given outcome would help the development of 
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Figure 1: VIP and VIM for each actigraphy variable as obtained from PLS and random forest, 
respectively, run separately in PWH (n=344) and HIV-negative individuals (n=119).    
 
Note: VIM are expressed as the percentage relative to that of the variable with the highest VIM. The 
random forest model additionally included age, gender, ethnicity, education and use of sleep 
medication; VIM for all variables, including potential confounders, are shown in Supplementary 
Figure 2 
 
Figure 2: Association between RU SATED sleep dimensions and global cognitive T-score in PWH 
(n=344) and HIV-negative individuals (n=119). Associations are expressed as differences in the 
median global T-scores with participants reporting ‘good’ sleep health as reference category and 
adjusting for potential confounders.  
 
Figure 3: Means (95% CI) of the 22 sleep variables (centered and scaled to unit variance) in PWH and 





















Table 1: Overview of the analytical approaches used to investigate the association between sleep health and cognitive function 
Analytical 
approach 






Multivariable regression analysis is 
used to describe the relationship 
between a set of independent 
variables (e.g. sleep parameters) 
and an outcome variable (e.g. a 
health outcome), through 
mathematical models (e.g. in linear 
regression the outcome is 
modelled as a linear combination 
of the independent variables). 
 
It allows the estimation of 
independent relationships 
between sleep variables. 
It is the most widely used method 
to investigate associations. Due to 
its popularity, the interpretation of 
regression analysis is widely 
accessible to non-statisticians.  
 
Due to issues related to the 
number and collinearity of sleep 
variables, its use is often limited to 
the inclusion of few pre-selected 
sleep variables, in order to avoid 
overfitting and instability in the 
estimation of model parameters.  
It often over simplify the 
relationships between the 
variables of interests and handling 
complex patterns of relationships 
is difficult. 
Statistical power depends mainly, 
other than the sample size, on the 
number of independent variables. 
There are no generally agreed 
methods for relating the sample 
size versus the number of 
independent variables. Common 
rules-of-thumbs recommend at 
least 15 or 30 observations per 




PLS-based methods reduce the 
input variables (e.g. sleep 
variables) to latent variables, and 
regress those latent variables 
against the outcome. Metrics such 
as the variable importance in 
prediction (VIP) are then calculated 
to rank each of the input variables 
according to their importance to 
predict the outcome.  
PLS regression is preferable to 
standard regression analysis when 
there are multiple input variables, 
and when these input variables are 
correlated. 
It is often difficult to interpret the 
model parameters that define the 
latent variables and those that 
relate these to the outcome. Both 
the latent variables and the 
outcome are modelled as linear 
combination (of the input variables 
and the latent variables, 
respectively). Therefore, non-linear 
relationships would be missed. 
It only handles continuous input 
variables and does not provide a 
straightforward way to account for 
potential confounders and effect 
modifiers (e.g. HIV-status).  
PLS-based methods are thought to 
provide significant advantages 
when analyzing small sample sizes 
or data with small number of 
observations to number of 
variables ratios. However, the 
optimal approach to assess 
statistical power for PLS-based 
approaches is still debated [46]. 
Statistical power should be 
determined based on various 
factors, such as distributional 
assumptions, characteristics of the 
input variables, or the strength of 
the relationships of interest [47]. 
Random forest Random forest is a non-parametric 
multi-variable ensemble technique 
The random selection of sampled 
observations and input variables 
It can be computationally intense 
and require longer times to train. 
Random forest has been reported 



















based on decision trees. Several 
different decision trees, each 
randomly selecting a subset of 
observations and input variables, 
are merged into one learner.  
helps the model to avoid 
overfitting. 
It can handle both categorical and 
quantitative variables and deal 
with missing data. 
It requires minimal assumptions 
about the type of associations 
between the outcome and the 
input variables, and can detect 
non-linear associations. 
The estimated relationship 
between the outcome and the 
input variables can be difficult to 
interpret with no direct measure 
to evaluate either the direction or 
magnitude of associations. 
small sample sizes [48]. 
In particular, it has been shown to 
perform well in term of statistical 
power, when the distributions of 
input variables were skewed [49]. 
Multidimensional 
construct 
Objective or subjective sleep 
parameters are combined using 
pre-defined criteria to derive 
several sleep dimensions. 
Associations between these sleep 
dimensions are then investigated, 
typically using regression-based 
approaches. 
It allows to integrate clinical 
knowledge and expert opinion into 
the analysis. 
There is not an objectively-defined 
paradigm that describes which are 
the dimensions that characterize 
sleep health are and how to best 
define and operationalize each 
dimension. 
Statistical power depends on the 
statistical method used to 
investigate associations between 
the outcome and the sleep 
dimensions. When using 
regression, the use of fewer sleep 
dimensions, compared to the 
individual sleep variables, 
improves statistical power. 
Latent class 
analysis (LCA) 
LCA helps recognizing latent sleep 
profiles that are shared by many 
individuals who, in turn, may 
experience similar risks for health 
outcomes. Latent sleep profiles 
refer to the specific combinations 
of several sleep characteristics 
experienced by individuals. 
It is flexible with respect to the 
distribution of sleep variables. 
It can accommodate different data 
types, including non-normal and 
skewed continuous sleep variables. 
The identification of sleep profiles 
is not oriented towards the 
assessment of relationships with 
health outcomes.  
The selection of the appropriate 
number and the underlying 
distribution of profiles is often 
challenging. 
 
Little is known about the exact 
effect of sample size on the ability 
to identify the set of underlying 
latent profiles. Simulations have 
shown that having a too small 
sample size often leads to choosing 
too few latent profiles to 
adequately describe the data-



















Table 2: Socio-demographic, lifestyle, clinical and HIV-related characteristics of study participants. 
Median (IQR) or n (%) PWH (n=344) HIV- negative (n=119) p 
Male gender 297 (86.3%) 80 (67.2%) <0.001 
Age [years] 57 (52, 62) 61 (57, 66) <0.001 
White ethnicity 305 (88.7%) 109 (91.6%) 0.37 
MSM/homosexual 272 (79.1%) 63 (52.9%) <0.001 
University degree or above 158 (45.9%) 61 (51.3%) 0.32 
Years of education 16 (12, 18) 16 (13, 18) 0.76 
BMI [Kg/cm2] 25.4 (23.5, 28.7) 25.8 (23.6, 29.7) 0.18 
Resting pulse oximetry [mm Hg] 96 (95, 98) 96 (95, 97) 0.68 
Use of sleep medication* 30 (8.7%) 2 (1.7%) 0.006 
Work schedule   0.006 
Day shift 120 (35.1%) 60 (51.7%)  
Other/Irregular shift 57 (16.7%) 13 (11.2%)  
Retired/Don’t work 165 (48.3%) 43 (37.1%)  
Current alcohol use 279 (81.1%) 109 (91.6%) 0.007 
Current smoking 90 (26.2%) 18 (15.1%) 0.01 
Current recreational drugs 92 (26.7%) 17 (14.3%) 0.006 
Ever injected drugs 32 (9.3%) 2 (1.7%) 0.004 
Current CD4+ count [cells/µL] 630 (483, 835) N/A N/A 
Nadir CD4+ count [cells/µL] 190 (87, 290) N/A N/A 
Years since HIV diagnosis 17.6 (10.8, 24.6) N/A N/A 
On antiretroviral treatment 316 (91.9%) N/A N/A 
HIV RNA <40 copies/mL 332 (97.1%) N/A N/A 
Global T-score  50.0 (44.2, 54.9) 52.0 (48.3, 55.6) 0.01 
Sleep duration [h] 7.0 (6.3, 7.6) 7.2 (6.7, 7.6) 0.12 
Maintenance efficiency [%] 88.7 (84.4, 91.4) 90.2 (86.2, 92.2) 0.01 
WASO [minutes] 54 (40, 74) 49 (35, 69) 0.02 
Note: PWH: people with HIV; MSM: men who have sex with other men; * These include 
Amitriptyline (5 PWH), Nitrazepam (2 PWH), Nytol (2 PWH), Zopiclone (13 PWH and 1 HIV-negative), 




















Table 3: Association of average sleep duration, WASO and maintenance efficiency with the global 
cognitive T-score, as estimated via rank regression, adjusting for age, gender, ethnicity, education 
and ongoing use of sleep medication. 
Sleep measure 
PWH (n=344) HIV-negative (n=119) p 
interaction adj. rho (95% CI)  p adj. rho (95% CI)   p 
Univariable analysis      
Average duration  0.08 (-0.02, 0.17) 0.12 -0.02 (-0.20, 0.15) 0.78 0.49 
Absolute value of median-
centered average duration 
-0.04 (-0.14, 0.05) 0.36 -0.21 (-0.38, -0.04) 0.02 0.71 
Average WASO -0.03 (-0.13, 0.07) 0.55 0.16 (-0.02, 0.34) 0.08 0.27 
Average maintenance efficiency  0.06 (-0.04, 0.16) 0.25 -0.16 (-0.35, 0.01) 0.07 0.18 
Multivariable analysis      
Absolute value of median-
centered average duration 
-0.03 (-0.13, 0.06) 0.51 -0.25 (-0.43, -0.07) 0.008 0.64 
Average WASO 0.21 (-0.09, 0.51) 0.16 0.27 (-0.51, 1.06) 0.49 0.71 
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